SCHEMBL16076221

SCHEMBL16076221

CCCCn1c(=O)c2c(nc(C#CCO)n2Cc2ccc(Cl)cc2)n(C)c1=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.54
▸ TRPC5 Q9UL62 3/20 0.51
▸ TRPC4 Q9UBN4 2/20 0.51
▸ KCNH2 Q12809 1/20 0.51
▸ TP53 P04637 3/20 0.50
▸ TSHR P16473 3/20 0.48
▸ POLB P06746 2/20 0.48
▸ RAB9A P51151 1/20 0.48
▸ TRPC1 P48995 1/20 0.47
▸ LMNA P02545 2/20 0.47
▸ GAA P10253 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ ATM Q13315 1/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ CYP1A2 P05177 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ RECQL P46063 1/20 0.45
▸ ALDH1A1 P00352 1/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ NPSR1 Q6W5P4 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19505608 0.86 TRPC5 (0.49) MAPTTRPC5TRPC4KCNH2TP53
SCHEMBL30149467 0.84 TRPC5 (0.56) MAPTTRPC5TRPC4KCNH2TP53
SCHEMBL30149527 0.84 TRPC5 (0.60) MAPTTRPC5TRPC4KCNH2TP53
SCHEMBL30149367 0.82 TRPC5 (0.57) MAPTTRPC5TRPC4KCNH2TP53
SCHEMBL30149505 0.82 TRPC5 (0.57) MAPTTRPC5TRPC4KCNH2TP53
SCHEMBL16029490 0.81 P2RX3 (0.47) MAPTTRPC5TRPC4KCNH2TRPC1
SCHEMBL30149323 0.81 TRPC5 (0.56) MAPTTRPC5TRPC4KCNH2TP53
SCHEMBL16076164 0.80 MAPT (0.61) MAPTTRPC5TRPC4KCNH2TP53
SCHEMBL16076165 0.80 TSHR (0.68) MAPTTRPC5TRPC4KCNH2TP53
SCHEMBL16076179 0.80 MAPT (0.61) MAPTTRPC5TRPC4KCNH2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9969736-B2 Substituted xanthines and methods of use thereof HYDRA BIOSCIENCES, INC. (US) 2018-05-15 — — US disclosed
US-20170305910-A1 Substituted Xanthines and Methods of Use Thereof BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2017-10-26 — — US disclosed
US-20160237089-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF HYDRA BIOSCIENCES, INC. 2016-08-18 — — US disclosed
US-20140275071-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF HYDRA BIOSCIENCES, INC. (US) 2014-09-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170305910-A1 Substituted Xanthines and Methods of Use Thereof TRPC5, TRPC7, TRPC4 MAPT 2951/4885TRPC5 1/4885TRPC4 3/4885
US-20140275071-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF TRPC5, TRPC7, TRPC4 MAPT 2951/4885TRPC5 1/4885TRPC4 3/4885
US-20160237089-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF TRPC5, TRPC7, TRPC4 MAPT 2951/4885TRPC5 1/4885TRPC4 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback